ONMD Quote, Financials, Valuation and Earnings

DarioHealth Corp. has a net margin of -418.64% compared to OneMedNet Corp.'s net margin of -41.48%. OneMedNet Corp.'s return on equity of -- beat DarioHealth Corp.'s return on equity of -41.55%.

OneMedNet Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand DarioHealth Corp. has an analysts' consensus of $18.25 which suggests that it could grow by 54.14%. Given that DarioHealth Corp. has higher upside potential than OneMedNet Corp., analysts believe DarioHealth Corp. is more attractive than OneMedNet Corp..

OneMedNet Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.716%.

OneMedNet Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OneMedNet Corp. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

OneMedNet Corp. quarterly revenues are $177K, which are smaller than DarioHealth Corp. quarterly revenues of $5M. OneMedNet Corp.'s net income of -$741K is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, OneMedNet Corp.'s price-to-earnings ratio is -- while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OneMedNet Corp. is 136.88x versus 6.57x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

National Research Corp. has a net margin of -418.64% compared to OneMedNet Corp.'s net margin of 11.54%. OneMedNet Corp.'s return on equity of -- beat National Research Corp.'s return on equity of 61.55%.

OneMedNet Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that OneMedNet Corp. has higher upside potential than National Research Corp., analysts believe OneMedNet Corp. is more attractive than National Research Corp..

OneMedNet Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.

OneMedNet Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 3.03% to investors and pays a quarterly dividend of $0.12 per share. OneMedNet Corp. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

OneMedNet Corp. quarterly revenues are $177K, which are smaller than National Research Corp. quarterly revenues of $34.6M. OneMedNet Corp.'s net income of -$741K is lower than National Research Corp.'s net income of $4M. Notably, OneMedNet Corp.'s price-to-earnings ratio is -- while National Research Corp.'s PE ratio is 22.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OneMedNet Corp. is 136.88x versus 2.60x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Predictive Oncology, Inc. has a net margin of -418.64% compared to OneMedNet Corp.'s net margin of -2156852.78%. OneMedNet Corp.'s return on equity of -- beat Predictive Oncology, Inc.'s return on equity of -1065.31%.

OneMedNet Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Predictive Oncology, Inc. has an analysts' consensus of -- which suggests that it could grow by 956.34%. Given that Predictive Oncology, Inc. has higher upside potential than OneMedNet Corp., analysts believe Predictive Oncology, Inc. is more attractive than OneMedNet Corp..

OneMedNet Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Predictive Oncology, Inc. has a beta of 1.354, suggesting its more volatile than the S&P 500 by 35.357%.

OneMedNet Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Predictive Oncology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OneMedNet Corp. pays -- of its earnings as a dividend. Predictive Oncology, Inc. pays out -- of its earnings as a dividend.

OneMedNet Corp. quarterly revenues are $177K, which are larger than Predictive Oncology, Inc. quarterly revenues of $3.6K. OneMedNet Corp.'s net income of -$741K is higher than Predictive Oncology, Inc.'s net income of -$77.6M. Notably, OneMedNet Corp.'s price-to-earnings ratio is -- while Predictive Oncology, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OneMedNet Corp. is 136.88x versus 13.06x for Predictive Oncology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of -418.64% compared to OneMedNet Corp.'s net margin of 9.46%. OneMedNet Corp.'s return on equity of -- beat Spok Holdings, Inc.'s return on equity of 10.88%.

OneMedNet Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 61.29%. Given that Spok Holdings, Inc. has higher upside potential than OneMedNet Corp., analysts believe Spok Holdings, Inc. is more attractive than OneMedNet Corp..

OneMedNet Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.

OneMedNet Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.6% to investors and pays a quarterly dividend of $0.31 per share. OneMedNet Corp. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

OneMedNet Corp. quarterly revenues are $177K, which are smaller than Spok Holdings, Inc. quarterly revenues of $33.9M. OneMedNet Corp.'s net income of -$741K is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, OneMedNet Corp.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OneMedNet Corp. is 136.88x versus 1.93x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.